Anti-influenza drugs: the development of sialidase inhibitors.

作者: Mark von Itzstein , Robin Thomson

DOI: 10.1007/978-3-540-79086-0_5

关键词:

摘要: Viruses, particularly those that are harmful to humans, the 'silent terrorists' of twenty-first century. Well over four million humans die per annum as a result viral infections alone. The scourge influenza virus has plagued mankind throughout ages. fact new strains emerge on regular basis, out Asia, establishes continual socio-economic threat mankind. arrival highly pathogenic avian H5N1 heightened potential human pandemic point where many countries have put in place 'preparedness plans' defend against such an outcome. discovery first designer sialidase inhibitor and anti-influenza drug Relenza, subsequently Tamiflu, now inspired number continuing efforts towards next generation drugs. Such drugs may act 'first-line-of-defence' spread infection buy time for necessary vaccine development setting. Furthermore, can develop resistance therapeutics makes these extremely important. An overview role virus-associated glycoprotein (neuraminidase) some most recent developments based inhibition is provided this chapter.

参考文章(185)
Alan W Hampson, John S Mackenzie, The influenza viruses. The Medical Journal of Australia. ,vol. 185, ,(2006) , 10.5694/J.1326-5377.2006.TB00705.X
Oxford Js, Zanamivir (Glaxo Wellcome). IDrugs : the investigational drugs journal. ,vol. 3, pp. 447- ,(2000)
David P. Calfee, Frederick G. Hayden, New approaches to influenza chemotherapy. Neuraminidase inhibitors. Drugs. ,vol. 56, pp. 537- 553 ,(1998) , 10.2165/00003495-199856040-00003
John Treanor, Frederick G Hayden, Luis Barroso, Larisa Gubareva, Efficacy and tolerability of the oral neuraminidase inhibitor peramivir in experimental human influenza: randomized, controlled trials for prophylaxis and treatment. Antiviral Therapy. ,vol. 10, pp. 901- 910 ,(2005)
P. M. Colman, C. W. Ward, Structure and Diversity of Influenza Virus Neuraminidase Current Topics in Microbiology and Immunology. ,vol. 114, pp. 177- 255 ,(1985) , 10.1007/978-3-642-70227-3_5
Susan M. Wintermeyer, Milap C. Nahata, Rimantadine: A Clinical Perspective: Annals of Pharmacotherapy. ,vol. 29, pp. 299- 310 ,(1995) , 10.1177/106002809502900312
Anthony P. Corfield, Roland Schauer, Metabolism of Sialic Acids Springer Vienna. pp. 195- 261 ,(1982) , 10.1007/978-3-7091-8680-0_9
Georg Herrler, Jürgen Hausmann, Hans-Dieter Klenk, Sialic Acid as Receptor Determinant of Ortho- and Paramyxoviruses Biology of the Sialic Acids. pp. 315- 336 ,(1995) , 10.1007/978-1-4757-9504-2_9
R. Schauer, Sialic acids : chemistry, metabolism and function Springer-Verlag. ,(1982)